Electromed, Inc. Financial Summary

Quick Answer

Electromed, Inc. reported Total Revenue of $64.00 million for fiscal year 2025.

Electromed, Inc. — Key Financials by Year

Metric 2025 2024 2023 2022 2021 2020
Total Revenue $64.00M
+17.0%
$54.72M
+13.8%
$48.07M
+15.4%
$41.66M
+16.5%
$35.76M
+10.1%
$32.47M
+3.7%
Revenue (ASC 606) $64.00M
+17.0%
$54.72M
Net Income $7.54M
+46.3%
$5.15M
+62.7%
$3.17M
+37.4%
$2.31M
-2.4%
$2.36M
-43.2%
$4.16M
+110.1%
Diluted EPS $0.85
+46.6%
$0.58
+61.1%
$0.36
+38.5%
$0.26
-3.7%
$0.27
-42.6%
$0.47
+104.3%
Total Assets $53.80M
+3.0%
$52.23M
+14.0%
$45.81M
+10.7%
$41.36M
+11.5%
$37.11M
+11.6%
$33.24M
+13.1%
Cash and Equivalents $15.29M
-4.9%
$16.08M
+118.1%
$7.37M
-9.6%
$8.15M
-31.4%
$11.89M
+13.5%
$10.48M
Long-Term Debt
Stockholders Equity $43.21M
-3.0%
$44.55M
+18.3%
$37.67M
+10.2%
$34.17M
+5.4%
$32.42M
+7.2%
$30.25M
+17.5%
R&D Expense $996.0K
+51.8%
$656.0K
-28.4%
$916.0K
-32.4%
$1.36M
-21.3%
$1.72M
+64.0%
$1.05M
+80.0%
Operating Income $9.66M
+46.8%
$6.58M
+64.2%
$4.01M
+34.9%
$2.97M
-5.4%
$3.14M
-38.6%
$5.12M
+80.9%
Gross Profit $49.97M
+19.8%
$41.73M
+14.3%
$36.52M
+16.1%
$31.44M
+15.2%
$27.30M
+8.4%
$25.20M
+5.7%
Shares Outstanding 8.35M
-3.3%
8.64M
+1.0%
8.56M
+0.9%
8.48M
-0.7%
8.53M
-0.4%
8.57M
+1.9%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue December 31, 2025 $18.90M +16.3% +11.9%
Revenue (ASC 606) December 31, 2025 $18.90M +16.3% +11.9%
Net Income December 31, 2025 $2.76M +40.3% +29.3%
Diluted EPS December 31, 2025 $0.32 +45.5% +28.0%
Total Assets December 31, 2025 $54.91M +5.0% +2.4%
Cash and Equivalents December 31, 2025 $13.79M -15.1% -2.3%
Long-Term Debt September 30, 2017 $1.09M -4.5% -1.1%
Stockholders Equity December 31, 2025 $45.44M +4.2% +1.6%
R&D Expense December 31, 2025 $384.0K +53.0% +59.3%
Operating Income December 31, 2025 $3.62M +42.4% +35.6%
Gross Profit December 31, 2025 $14.82M +17.4% +12.3%
Shares Outstanding December 31, 2025 8.28M -3.2% -0.9%
  • Electromed, Inc. reported Total Revenue of $64.00 million for fiscal year 2025.
  • Electromed, Inc. showed an increase of +17.0% in Total Revenue compared to the prior fiscal year.
  • Electromed, Inc. reported Revenue (ASC 606) of $64.00 million for fiscal year 2025.
  • Electromed, Inc. showed an increase of +17.0% in Revenue (ASC 606) compared to the prior fiscal year.
  • Electromed, Inc. reported Net Income of $7.54 million for fiscal year 2025.
  • Electromed, Inc. showed an increase of +46.3% in Net Income compared to the prior fiscal year.
  • Electromed, Inc. reported Diluted EPS of $0.85 per share for fiscal year 2025.
  • Electromed, Inc. showed an increase of +46.6% in Diluted EPS compared to the prior fiscal year.
  • Electromed, Inc. reported Total Assets of $53.80 million for fiscal year 2025.
  • Electromed, Inc. showed an increase of +3.0% in Total Assets compared to the prior fiscal year.
  • Electromed, Inc. reported Cash and Equivalents of $15.29 million for fiscal year 2025.
  • Electromed, Inc. showed a decrease of -4.9% in Cash and Equivalents compared to the prior fiscal year.
  • Electromed, Inc. reported Long-Term Debt of $1.10 million for fiscal year 2017.
  • Electromed, Inc. showed a decrease of -4.3% in Long-Term Debt compared to the prior fiscal year.
  • Electromed, Inc. reported Stockholders Equity of $43.21 million for fiscal year 2025.
  • Electromed, Inc. showed a decrease of -3.0% in Stockholders Equity compared to the prior fiscal year.
  • Electromed, Inc. reported R&D Expense of $996.0 thousand for fiscal year 2025.
  • Electromed, Inc. showed an increase of +51.8% in R&D Expense compared to the prior fiscal year.
  • Electromed, Inc. reported Operating Income of $9.66 million for fiscal year 2025.
  • Electromed, Inc. showed an increase of +46.8% in Operating Income compared to the prior fiscal year.
  • Electromed, Inc. reported Gross Profit of $49.97 million for fiscal year 2025.
  • Electromed, Inc. showed an increase of +19.8% in Gross Profit compared to the prior fiscal year.
  • Electromed, Inc. reported Shares Outstanding of 8.35 million shares for fiscal year 2025.
  • Electromed, Inc. showed a decrease of -3.3% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment